Thank you @CaroleCW for posting this.
One obvious flaw in the study is there appears to be no control group of un-immunocompromised individuals.
Helen
1 Like
I know the NIHR press release doesn’t mention a comparator group of un-immunocompromised people but haven’t seen the detail of the Stravinsky study to know if there is or isn’t a control group . @GemmaBloodCancerUK do you have any details on this aspect of the study? Thanks
1 Like
Hi @CaroleCW, thank you for your question, and I do hope you’re doing okay. I will discuss this with the wider team on Monday to see if we can find an answer for you. I do hope that’s okay, and please don’t hesitate to reach out to us if you’d like to talk anything through at all.
Best wishes,
Tanya.
2 Likes
Hi @CaroleCW, I apologise for not coming back to you about this yet- we are looking into this, and I will let you know if we find anything. Thank you for your patience.
Best wishes,
Tanya.
1 Like
No rush, just that Helen above flagged it and I thought it was an interesting point to clarify
1 Like
Hi @CaroleCW, I do hope you’re doing okay today. We’ve looked into this with the help of our Clinical Trials Support Service team. It looks as though the study is still in its early stages and is not as yet underway. It may therefore take some time before they’re able to release more details about it.
I appreciate this doesn’t answer your question at this stage but I hope it’s somewhat helpful to know for now.
Best wishes,
Tanya.
3 Likes